35 results
ARS
2022 FY
PNT
POINT Biopharma Global Inc.
1 May 23
Annual report to shareholders
1:52pm
ability to recruit and enroll suitable patients in our clinical trials; the potential attributes and benefits of our product candidates; our ability … ; the design of the trial; its ability to recruit clinical trial investigators with the appropriate competencies and experience; competing clinical trials
424B5
93u9a77
14 Sep 22
Prospectus supplement for primary offering
4:12pm
424B5
tktrnhsxc 23
13 Sep 22
Prospectus supplement for primary offering
5:19pm
424B3
beopg uwu
11 Jul 22
Prospectus supplement
4:32pm
POS AM
v0qwwav43ri
1 Jul 22
Prospectus update (post-effective amendment)
4:17pm
S-3
vtml8wgobk
1 Jul 22
Shelf registration
4:13pm
424B3
vv2n34cy c2chhm9e
13 May 22
Prospectus supplement
8:18am
424B3
mewlv3lgt51vla82
31 Mar 22
Prospectus supplement
11:42am
POS AM
esz9hnk4767r2g4i8
25 Mar 22
Prospectus update (post-effective amendment)
8:41am
424B3
s37v4ld vz73vtetie
12 Nov 21
Prospectus supplement
8:41am
424B3
qqb a8ssuy
13 Aug 21
Prospectus supplement
5:25pm